Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-11 2024-11-08 240046
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-17 2025-01-30 240525
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2024-11-28 2025-04-28 244081
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-01-09 2025-03-27 247309
ONDANSETRON INJECTION 2MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1746
ONDANSETRON INJECTION 2MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1754
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2020-10-15 2020-11-26 126533
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-12 2019-11-22 93650
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-26 2019-11-14 94840
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-18 2019-08-06 86905
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-18 2019-07-16 86908
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-27 2019-08-21 87684
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2020-02-21 2020-05-08 106955
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2021-01-22 2021-03-18 132270
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2021-06-03 2021-08-05 140393
PEDIATRIX 160MG SOLUTION Resolved 2023-06-19 2023-06-27 195643
PEDIATRIX 160MG SOLUTION Resolved 2023-06-16 2023-06-27 195106
PEDIATRIX 160MG SOLUTION Resolved 2022-08-18 2023-06-27 167194

Showing 501 to 520 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-03-20 2025-03-20 253156
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-04-25 2025-04-25 255812
TEVA-DICLOFENAC SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2025-04-29 2025-04-29 256131
TEVA-DICLOFENAC-K 50MG TABLET Discontinued 2025-03-20 2025-03-20 253168
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85572
TEVA-DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85575
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
TEVA-EFAVIRENZ 600MG TABLET Discontinued 2025-04-29 2025-04-29 256134
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64855
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64858
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64861
TEVA-ENALAPRIL 16MG TABLET Discontinued 2018-10-19 2018-10-19 64866

Showing 161 to 180 of 299